Table 3.
Serotype | |||||
---|---|---|---|---|---|
Sample Period * | n | EHDV-1 | EHDV-2 | EHDV-6 | EHDV-2 + -6 |
2016 | 18 | 0 (0%) | 17 (94%) | 1 (6%) | 0 (0%) |
2017 | 31 | 0 (0%) | 8 (26%) | 22 (71%) | 1 (3%) |
2018 | 23 | 0 (0%) | 23 (100%) | 0 (0%) | 0 (0%) |
2019 | 41 | 19 (46%) | 11 (27%) | 10 (24%) | 1 (2%) |
2020 | 8 | 0 (0%) | 8 (100%) | 0 (0%) | 0 (0%) |
Total | 121 | 19 (16%) | 67 (55%) | 33 (27%) | 2 (2%) |
* 1 January to 31 December, a Number rt-qPCR positive/number samples (% positive), b Number rt-qPCR positive to EHDV, BTV, or both/number samples (% positive).